The activity of cathepsin D in saliva of cystic fibrosis patients
Cystic fibrosis (CF) is genetically determined illness, which is caused by the mutation in the CFTR gene. CFTR protein is also expressed in epithelial cells of parotid glands, therefore parotid glands are also affected in CF patients. Cathepsin D is one of the proteolitic cascade enzymes. Physiologi...
Saved in:
Published in | Folia histochemica et cytobiologica Vol. 45; no. 3; pp. 165 - 168 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Poland
Wydawnictwo Via Medica
01.01.2007
Via Medica |
Subjects | |
Online Access | Get full text |
ISSN | 0239-8508 1897-5631 |
DOI | 10.5603/4520 |
Cover
Loading…
Abstract | Cystic fibrosis (CF) is genetically determined illness, which is caused by the mutation in the CFTR gene. CFTR protein is also expressed in epithelial cells of parotid glands, therefore parotid glands are also affected in CF patients. Cathepsin D is one of the proteolitic cascade enzymes. Physiological wearing out result in occurrence of trace quantities of this enzyme in serum and body fluids, including saliva. Among different enzymes, saliva contains cathepsin D (CTSD, EC 3.4.23.5). The aim of this study was to determine cathepsin D activity in mixed saliva in cystic fibrosis patients and healthy controls. The study was performed in a group of 26 CF patients (10F, 16M). The results obtained in CF group was compared with the results of thirty healthy subjects (12F, 14M). From each subject 8 ml of mixed saliva was obtained: before and after the stimulation of saliva excretion using paraffin pledgets. Protein and glycoprotein content was assessed using Winzler's method. Protein concentration in controls and CF group before stimulation of excretion was 1.15+/-0.714 mg/mL and 1.54+/-0.925 mg/mL. After stimulation protein concentration in saliva has lowered to 0.88+/-0.77 mg/mL in CF group and 1.24+/-1.213 mg/mL in controls. Glycoprotein concentration in controls and in CF group was respectively: before stimulation 1.08+/-0.271 mg/mL and 1.05+/-0.344 mg/mL; after stimulation 0.92+/-0.292 mg/mL and 0.86+/-0.283 mg/mL. The activity of CTSD in controls was 45.9+/-24.98 Tyr nmol/mL/4h before stimulation and 109.3+/-56.94 Tyr nmol/mL/4h after stimulation of excretion. In CF group CTSD activity before stimulation was 134.5+/-81.80 Tyr nmol/mL/4h and after stimulation 134.4+/-62.18 Tyr nmol/mL/4h. Comparing the CTSD activity in both groups statistically significant difference has been revealed in samples collected before stimulation of excretion (p=0.013). The activity of cathepsin D in saliva of cystic fibrosis patient is significantly higher than in healthy controls before the stimulation of excretion with paraffin pledgets. |
---|---|
AbstractList | Cystic fibrosis (CF) is genetically determined illness, which is caused by the mutation in the CFTR gene. CFTR protein is also expressed in epithelial cells of parotid glands, therefore parotid glands are also affected in CF patients. Cathepsin D is one of the proteolitic cascade enzymes. Physiological wearing out result in occurrence of trace quantities of this enzyme in serum and body fluids, including saliva. Among different enzymes, saliva contains cathepsin D (CTSD, EC 3.4.23.5). The aim of this study was to determine cathepsin D activity in mixed saliva in cystic fibrosis patients and healthy controls. The study was performed in a group of 26 CF patients (10F, 16M). The results obtained in CF group was compared with the results of thirty healthy subjects (12F, 14M). From each subject 8 ml of mixed saliva was obtained: before and after the stimulation of saliva excretion using paraffin pledgets. Protein and glycoprotein content was assessed using Winzler's method. Protein concentration in controls and CF group before stimulation of excretion was 1.15+/-0.714 mg/mL and 1.54+/-0.925 mg/mL. After stimulation protein concentration in saliva has lowered to 0.88+/-0.77 mg/mL in CF group and 1.24+/-1.213 mg/mL in controls. Glycoprotein concentration in controls and in CF group was respectively: before stimulation 1.08+/-0.271 mg/mL and 1.05+/-0.344 mg/mL; after stimulation 0.92+/-0.292 mg/mL and 0.86+/-0.283 mg/mL. The activity of CTSD in controls was 45.9+/-24.98 Tyr nmol/mL/4h before stimulation and 109.3+/-56.94 Tyr nmol/mL/4h after stimulation of excretion. In CF group CTSD activity before stimulation was 134.5+/-81.80 Tyr nmol/mL/4h and after stimulation 134.4+/-62.18 Tyr nmol/mL/4h. Comparing the CTSD activity in both groups statistically significant difference has been revealed in samples collected before stimulation of excretion (p=0.013). The activity of cathepsin D in saliva of cystic fibrosis patient is significantly higher than in healthy controls before the stimulation of excretion with paraffin pledgets. Cystic fibrosis (CF) is genetically determined illness, which is caused by the mutation in the CFTR gene. CFTR protein is also expressed in epithelial cells of parotid glands, therefore parotid glands are also affected in CF patients. Cathepsin D is one of the proteolitic cascade enzymes. Physiological wearing out result in occurrence of trace quantities of this enzyme in serum and body fluids, including saliva. Among different enzymes, saliva contains cathepsin D (CTSD, EC 3.4.23.5). The aim of this study was to determine cathepsin D activity in mixed saliva in cystic fibrosis patients and healthy controls. The study was performed in a group of 26 CF patients (10F, 16M). The results obtained in CF group was compared with the results of thirty healthy subjects (12F, 14M). From each subject 8 ml of mixed saliva was obtained: before and after the stimulation of saliva excretion using paraffin pledgets. Protein and glycoprotein content was assessed using Winzler's method. Protein concentration in controls and CF group before stimulation of excretion was 1.15+/-0.714 mg/mL and 1.54+/-0.925 mg/mL. After stimulation protein concentration in saliva has lowered to 0.88+/-0.77 mg/mL in CF group and 1.24+/-1.213 mg/mL in controls. Glycoprotein concentration in controls and in CF group was respectively: before stimulation 1.08+/-0.271 mg/mL and 1.05+/-0.344 mg/mL; after stimulation 0.92+/-0.292 mg/mL and 0.86+/-0.283 mg/mL. The activity of CTSD in controls was 45.9+/-24.98 Tyr nmol/mL/4h before stimulation and 109.3+/-56.94 Tyr nmol/mL/4h after stimulation of excretion. In CF group CTSD activity before stimulation was 134.5+/-81.80 Tyr nmol/mL/4h and after stimulation 134.4+/-62.18 Tyr nmol/mL/4h. Comparing the CTSD activity in both groups statistically significant difference has been revealed in samples collected before stimulation of excretion (p=0.013). The activity of cathepsin D in saliva of cystic fibrosis patient is significantly higher than in healthy controls before the stimulation of excretion with paraffin pledgets.Cystic fibrosis (CF) is genetically determined illness, which is caused by the mutation in the CFTR gene. CFTR protein is also expressed in epithelial cells of parotid glands, therefore parotid glands are also affected in CF patients. Cathepsin D is one of the proteolitic cascade enzymes. Physiological wearing out result in occurrence of trace quantities of this enzyme in serum and body fluids, including saliva. Among different enzymes, saliva contains cathepsin D (CTSD, EC 3.4.23.5). The aim of this study was to determine cathepsin D activity in mixed saliva in cystic fibrosis patients and healthy controls. The study was performed in a group of 26 CF patients (10F, 16M). The results obtained in CF group was compared with the results of thirty healthy subjects (12F, 14M). From each subject 8 ml of mixed saliva was obtained: before and after the stimulation of saliva excretion using paraffin pledgets. Protein and glycoprotein content was assessed using Winzler's method. Protein concentration in controls and CF group before stimulation of excretion was 1.15+/-0.714 mg/mL and 1.54+/-0.925 mg/mL. After stimulation protein concentration in saliva has lowered to 0.88+/-0.77 mg/mL in CF group and 1.24+/-1.213 mg/mL in controls. Glycoprotein concentration in controls and in CF group was respectively: before stimulation 1.08+/-0.271 mg/mL and 1.05+/-0.344 mg/mL; after stimulation 0.92+/-0.292 mg/mL and 0.86+/-0.283 mg/mL. The activity of CTSD in controls was 45.9+/-24.98 Tyr nmol/mL/4h before stimulation and 109.3+/-56.94 Tyr nmol/mL/4h after stimulation of excretion. In CF group CTSD activity before stimulation was 134.5+/-81.80 Tyr nmol/mL/4h and after stimulation 134.4+/-62.18 Tyr nmol/mL/4h. Comparing the CTSD activity in both groups statistically significant difference has been revealed in samples collected before stimulation of excretion (p=0.013). The activity of cathepsin D in saliva of cystic fibrosis patient is significantly higher than in healthy controls before the stimulation of excretion with paraffin pledgets. |
Author | Minarowski, Lukasz Sands, Dorota Dabrowska, Ewa Minarowska, Alina Karwowska, Alicja |
Author_xml | – sequence: 1 givenname: Alina surname: Minarowska fullname: Minarowska, Alina email: minar@mp.pll organization: 3rd Department of Children's Diseases, Medical University of Białystok, Poland. minar@mp.pll – sequence: 2 givenname: Lukasz surname: Minarowski fullname: Minarowski, Lukasz – sequence: 3 givenname: Alicja surname: Karwowska fullname: Karwowska, Alicja – sequence: 4 givenname: Dorota surname: Sands fullname: Sands, Dorota – sequence: 5 givenname: Ewa surname: Dabrowska fullname: Dabrowska, Ewa |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17951164$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkEtrwzAQhEVJaV79C8X00JtbrV6RjyF9BQK9pGeztuRGwbFSyw7k31ckaQ-97MLsxzCzYzJofGMJmQJ9lIryJyEZvSIj0NkslYrDgIwo41mqJdVDMg5hS2kEBdyQIcwyCaDEiMzXG5tg2bmD646Jr5ISu43dB9ckz0kcAWt3wNPhGDpXJpUrWh9cSPbYOdt0YUquK6yDvb3sCfl8fVkv3tPVx9tyMV-lhlPWpSXLmFaCarBGoOaZoSZDZqSgCipmS8BCKxAKGegCyyhVUnOjpeCqtJpPyPLsazxu833rdtgec48uPwm-_cqxjQlrmxdWm1hRMKxAFHKGWnJqGYXKxixGRq-Hs9e-9d-9DV2-c6G0dY2N9X3IlRbAQPII3v8Dt75vm9gzZ8BpJvgMInR3gfpiZ81ftt8v8x-vI3tZ |
ContentType | Journal Article |
Copyright | Copyright Folia Histochemica et Cytobiologica 2007 |
Copyright_xml | – notice: Copyright Folia Histochemica et Cytobiologica 2007 |
DBID | CGR CUY CVF ECM EIF NPM 3V. 4T- 7QL 7QP 7T5 7TK 7TO 7U7 7X7 7XB 88A 88E 8AO 8FD 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI BYOGL C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M7P MBDVC P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U RC3 7X8 DOA |
DOI | 10.5603/4520 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Docstoc Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Immunology Abstracts Neurosciences Abstracts Oncogenes and Growth Factors Abstracts Toxicology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection East Europe, Central Europe Database (ProQuest) Environmental Sciences and Pollution Management ProQuest One ProQuest Central Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Research Library Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Docstoc Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central Basic Toxicology Abstracts East Europe, Central Europe Database ProQuest SciTech Collection ProQuest Medical Library Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BYOGL name: East Europe, Central Europe Database (ProQuest) url: https://proxy.k.utb.cz/login?url=https://search.proquest.com/eastcentraleurope sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1897-5631 |
EndPage | 168 |
ExternalDocumentID | oai_doaj_org_article_be8d17942af14b57a8530e201fe302d5 1372797561 17951164 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 29H 2WC 36B 3EA 53G 5GY 5VS 7X7 88E 8AO 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 ABMXE ABUWG ACIHN ACPRK ADBBV AEAQA AENEX AEUYN AFKRA AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI BYOGL C1A CCPQU CGR CS3 CUY CVF DIK DU5 DWQXO E3Z EBD EBS ECM EIF EJD EMB EMOBN EOJEC F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HCIFZ HH5 HMCUK IPNFZ KQ8 LK8 M1P M2O M7P NPM OBODZ OK1 P2P PHGZT PIMPY PQQKQ PROAC PSQYO Q2X RIG RNS SV3 TR2 UKHRP Y2W ZXP ~02 3V. 4T- 7QL 7QP 7T5 7TK 7TO 7U7 7XB 88A 8FD 8FK C1K FR3 H94 K9. MBDVC OVT P64 PHGZM PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U RC3 7X8 PUEGO |
ID | FETCH-LOGICAL-d302t-c292864081ed4a839d0d9a2d54061f2ec1ab86146a218bacf2ef583d85436ce83 |
IEDL.DBID | DOA |
ISSN | 0239-8508 |
IngestDate | Wed Aug 27 01:21:49 EDT 2025 Fri Jul 11 13:06:09 EDT 2025 Fri Jul 25 10:51:56 EDT 2025 Thu Apr 03 07:00:00 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-d302t-c292864081ed4a839d0d9a2d54061f2ec1ab86146a218bacf2ef583d85436ce83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doaj.org/article/be8d17942af14b57a8530e201fe302d5 |
PMID | 17951164 |
PQID | 213094371 |
PQPubID | 34373 |
PageCount | 4 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_be8d17942af14b57a8530e201fe302d5 proquest_miscellaneous_68412153 proquest_journals_213094371 pubmed_primary_17951164 |
PublicationCentury | 2000 |
PublicationDate | 2007-01-01 |
PublicationDateYYYYMMDD | 2007-01-01 |
PublicationDate_xml | – month: 01 year: 2007 text: 2007-01-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Poland |
PublicationPlace_xml | – name: Poland – name: Bialystok |
PublicationTitle | Folia histochemica et cytobiologica |
PublicationTitleAlternate | Folia Histochem Cytobiol |
PublicationYear | 2007 |
Publisher | Wydawnictwo Via Medica Via Medica |
Publisher_xml | – name: Wydawnictwo Via Medica – name: Via Medica |
SSID | ssj0056041 |
Score | 1.7698934 |
Snippet | Cystic fibrosis (CF) is genetically determined illness, which is caused by the mutation in the CFTR gene. CFTR protein is also expressed in epithelial cells of... |
SourceID | doaj proquest pubmed |
SourceType | Open Website Aggregation Database Index Database |
StartPage | 165 |
SubjectTerms | Adolescent Cathepsin D - analysis Cathepsin D - metabolism Cystic Fibrosis - enzymology Excretion Female Humans Male Reference Standards Saliva - chemistry Saliva - enzymology |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8QgEJ74iMaYGN-u64OD18aWAqUn42uzMdGTm-ytgQLGy3a168F_7wyte9NLD5BQwgzzAr4P4MpnxijhUXlNJojCTCU2lDJRuhBBqtraWBp4flHjiXiayml_N6ftr1X-2sRoqF1TU438mqOxLUVeZDfzj4RIo-hwtWfQWIV1Qi6j3KuYLvMt9OWRuJKebyYaA5FN2EYbgc35tZBE8B1R-v8OLaOLGe3CTh8bsttOmHuw4mf7sNGxRX4fwC2KlNE7BKJ7YE1gEXJ1jsk-e2D4aQ0d68SOb0JfZgFT4aZ9b1kPntoewmT0-Ho_TnoGhMTlKV8kNS-5VgLdtnfCYCzjUlca7iS54cB9nRmr0cEqg57amhqbgtS501LkqvY6P4K1WTPzJ8CMNYXjqeQoNRGCKG1qPc98Kp3nss4GcEerUc07kIuKYKdjQ_P5VvVaXFmvHe1gbkImrCwMOvvUYwwRPM7XyQEMf9ey6vdCWy0lN4DLZS8qMZ1MmJlvvtpKaUEoF_kAjjsBLKeBf8OQUInTf0cewlZXc6XSyBmsLT6__DkGCwt7EVXiB_QHvPk priority: 102 providerName: ProQuest |
Title | The activity of cathepsin D in saliva of cystic fibrosis patients |
URI | https://www.ncbi.nlm.nih.gov/pubmed/17951164 https://www.proquest.com/docview/213094371 https://www.proquest.com/docview/68412153 https://doaj.org/article/be8d17942af14b57a8530e201fe302d5 |
Volume | 45 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV09T8MwED1BEQghIb4pheKBNWri2I4zUmhVIVEhRKVukR3bEktbkXbov-fspBULYmHJYA8--y5-56_3AB5sopRgFoNXJcxLmIlIu5xHQmbMcVFqHbYGXsdiNGEvUz79IfXl74TV9MD1wPW0lcYHDVUuYZpnCvEltghbzqYxNYG9FDFvs5iq52CE8aBZ6V9uRhJzkAM4wukBi9Me417bOxD0_55VBnQZnsBxkxaSx9qcU9ixszPYr4Ui1-fwiN4k_gmCV3ogc0cC2-oC1_nkmeCnUv5EJ1SsPfEycbgKnlefFWl4U6sLmAwHH0-jqBE_iAz2axmVNKdSMERsa5jCNMbEJlfYYY_AjtoyUVoitgqFIK1ViUWOy9RIzlJRWpleQms2n9lrIEqrzNCYU3QYc47lOtaWJjbmxlJeJm3o-9EoFjW_ReEZp0MB-qFo_FD85Yc2dDZjWTS_QVVQRMicpRk2cb-txfj1hxJqZuerqhCSeYKLtA1XtQO2ZmBrmA0KdvMf5nXgsN6V9Zsnt9Bafq3sHaYTS92F3WyadWGvPxi_vXdDHH0Da8jIEg |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwzV3NTtwwEB7BIihCaiktdKEtPtBjIHFsr3PgAAW6lAUuINFTsGO7WiEliOyqWh6FV-HlGOdnD0jlhsQlB1tynMx45vN4PB_Alo2UEsyi8qqIeQozEWiX8EDIHnNcZFpXoYHTM9G_ZL-v-NUMPLR3YXxaZWsTK0NtiszHyHcoGtuExb2oSaA8sZN_uD0rd48PUJY_KD06vPjZDxoGgcDEIR0FGU2oFAzdnjVMIRYwoUkUNdy7MUdtFikt0UEJhZ5OqwybHJexkZzFIrMyxnFnYQ43FZR1YG7_z_mvQWvnESpUvJj-dmggEecswBKaIGyOdxj3_OEVCcD_kWvlwY4-wGP77XXiys32eKS3s_tnZSHf5s9ZhvcNcCZ7taZ_hBmbr8B8TaU5-QR7qO_EX9LwXBikcKSqR3tbDnNyQPBRKn_mVXVMfGlq4oYaAcKwJE1l2fIzXL7K_Fehkxe5_QJEadUzNOQUVZo5xxIdaksjG3JjKc-iLux7Waa3dQWQ1NfkrhqKu79ps8RTbaXx5o0qFzHNewqRUGgRYDmL8zW8Cxut8NLGUJTpVHJd2Jz24gr3xzYqt8W4TIVkvgRI3IW1Wn2m08C3IV4WbP3FkTfhXf_idJAOjs9ONmCxDk77GNJX6IzuxvYboqqR_t6oN4Hr11aaJwbgLgc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+activity+of+cathepsin+D+in+saliva+of+cystic+fibrosis+patients&rft.jtitle=Folia+histochemica+et+cytobiologica&rft.au=Minarowska%2C+Alina&rft.au=Minarowski%2C+Lukasz&rft.au=Karwowska%2C+Alicja&rft.au=Sands%2C+Dorota&rft.date=2007-01-01&rft.issn=0239-8508&rft.volume=45&rft.issue=3&rft.spage=165&rft_id=info:doi/10.5603%2F4520&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0239-8508&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0239-8508&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0239-8508&client=summon |